NCT02237742View on ClinicalTrials.gov

A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

PF-06427878

Intravenous, 100 micrograms, single dose, 30 minute infusion

Trial Locations (1)

NG11 6JS

Quotient Clinical Ltd, Ruddington

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY